Literature DB >> 12379008

Cranial nerve preservation after radiosurgery of vestibular schwannomas.

F Unger1, C Walch, O Schröttner, S Eustacchio, B Sutter, G Pendl.   

Abstract

Radiosurgery is a management approach used to treat patients with vestibular schwannomas. The goals are long-term tumour growth control, maintenance of cranial nerve function and prevention of new deficiencies. We sought to determine long-term outcomes measuring the potential benefits against the neurological risks of primary radiosurgery. Gamma Knife radiosurgery was applied as a treatment modality for 289 patients with vestibular schwannomas from April 1992 to April 2002. The long-term results of 100 patients who underwent radiosurgery were evaluated. 60 patients received a primary treatment, 40 other cases presented with previously performed subtotal microsurgical resection or recurrence of disease (12-96 months, median 39). The median treatment volume was 3.4 ccm and the median dose to the tumour margin was 13 Gy. The median patient follow-up time was 76 months (range 60-120 months). Four tumours progressed after primary radiosurgery. Tumour control rate was 96%. Useful hearing (Gardner-Robertson I/II) was preserved in 16 patients (55%). Clinical neurological improvement occurred in 50%. Adverse effects comprised neurological symptoms (incomplete facial palsy) (House-Brackman II/III) in six cases (four recovered completely), mild transient trigeminal neuropathy in five cases, and morphological changes displaying rapid enlargement of preexisting macrocysts in two patients and tumour growth in two other patients. Microsurgical resection was performed in four cases (4%) and two patients underwent a shunting procedure because of hydrocephalus formation (2%). In patients who had undergone previous microsurgery, no new cranial nerve deficit was observed. Radiosurgery is an effective method for growth control of vestibular schwannomas and is associated with both a low mortality rate and a good quality of life. Accordingly, for the preservation of cranial nerve function radiosurgery is a useful method for the management of properly selected patients and is comparable to microsurgery.

Entities:  

Mesh:

Year:  2002        PMID: 12379008     DOI: 10.1007/978-3-7091-6117-3_9

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

1.  Small Vestibular Schwannomas: Does Surgery Remain a Viable Treatment Option?

Authors:  Amjad N Anaizi; Vincent V DiNapoli; Myles Pensak; Philip V Theodosopoulos
Journal:  J Neurol Surg B Skull Base       Date:  2015-10-08

2.  Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

Authors:  Susan C Pannullo; Justin F Fraser; Jennifer Moliterno; William Cobb; Philip E Stieg
Journal:  J Neurooncol       Date:  2010-12-09       Impact factor: 4.130

3.  [Stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neuromas].

Authors:  F Unger; K Dominikus; K Haselsberger
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

4.  Long-term Outcomes of Gamma Knife Stereotactic Radiosurgery of Vestibular Schwannomas.

Authors:  Kang-Min Kim; Chul-Kee Park; Hyun-Tai Chung; Sun Ha Paek; Hee-Won Jung; Dong Gyu Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

Review 5.  Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery.

Authors:  Isaac Yang; Michael E Sughrue; Seunggu J Han; Shanna Fang; Derick Aranda; Steven W Cheung; Lawrence H Pitts; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

6.  Systematic Review of Hearing Preservation After Radiotherapy for Vestibular Schwannoma.

Authors:  Adam R Coughlin; Tyler J Willman; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

7.  Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) Practice Guideline.

Authors:  May N Tsao; Arjun Sahgal; Wei Xu; Antonio De Salles; Motohiro Hayashi; Marc Levivier; Lijun Ma; Roberto Martinez; Jean Régis; Sam Ryu; Ben J Slotman; Ian Paddick
Journal:  J Radiosurg SBRT       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.